Patent · US Active

Peptide carrier fusion proteins as allergy vaccines

US9844591B2 · kind B2 · utility

1Cited by

3References

7Claims

0Family size

Assignee

BIOMAY AG · AT

Inventors

Katarzyna Niespodziana · Wien, AT
Margarete Focke-Tejkl · Wien, AT
Susanne Vrtala · Wien, AT
Srinita Banerjee · Wien, AT
Kuan-Wei Chen · Tainan, TW
Milena Weber · Wien, AT
Rudolf Valenta · Theresienfeld, AT
Katharina Marth · Wien, AT

Key dates

Filing date	May 1, 2015
Grant date	Dec 19, 2017
Priority date	—
Expiry date	Aug 21, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2730/10134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.